Search company, investor...

Hemosphere (formerly GRAFTcath)

Hemosphere (formerly GRAFTcath) has not claimed their Profile.

Want to better differentiate Hemosphere (formerly GRAFTcath) between your competitors? Show buyers how.

Hemosphere (formerly GRAFTcath) Logo

Why does Hemosphere (formerly GRAFTcath) win vs. MedShape?

Show Hemosphere (formerly GRAFTcath)'s primary competitive advantage
Show Hemosphere (formerly GRAFTcath)'s competitive differentiation

Hemosphere (formerly GRAFTcath)'s alternatives and competitors

See how Hemosphere (formerly GRAFTcath) compares to similar products. Hemosphere (formerly GRAFTcath)'s top competitors include MedShape, Respicardia, and Access Scientific.

MedShape Logo

MedShape is a medical device company working to develop and commercialize a portfolio of surgical solutions that use its shape memory technologies to address the increa…

Hemosphere (formerly GRAFTcath) vs. MedShape

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more

Compete with Hemosphere (formerly GRAFTcath)?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

Compare Hemosphere (formerly GRAFTcath) to Competitors


GRAFTcath is a medical device company developing vascular access products for hemodialysis.

Claros Diagnostics

Claros Diagnostics is an early stage device company developing a POC multiplex diagnostic focused on a biomarker panel for prostate cancer.

Primaeva Medical

Primaeva Medical is an early stage medical device company developing a skin tightening and rejuvenation dermatological device

ExploraMed V

ExploraMed is a medical technology incubation company dedicated to the identification, creation and development of medical device solutions. ExploraMed creates ideas in the fields of clinical, engineering, legal, strategic marketing, and financing, while focusing on efficient and timely development.

UroCor Labs

UroCor Labs aims to provide a menu of diagnostic services to assist in detecting, diagnosing, treating and managing prostate cancer, bladder cancer, kidney stones, and other complex urologic disorders.

Vascular Closure Systems

a medical device company, based in part on intellectual property of CardioVascular Technologies, Inc. (, and is focused on the development and commercialization of the vascular access closure technology for the Interventional Cardiology market. The company is comprised of several seasoned medical device professionals and physicians, with a proven record of innovation, clinical acumen, access to the industry and successful commercialization of multiple medical device technologies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.